ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 686428 Null 0.0430277102950697 -0.020759593
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0430277102950697 0.20475211
NSC 708431 Null 0.0430277102950697 -0.12713084
NSC 709237 Camptothecin Derivative 0.0430277102950697 -0.12433174
NSC 710464 AFP464 0.0430277102950697 -0.078180774
NSC 726671 Null 0.0430277102950697 0.16778244
NSC 728856 5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride 0.0430277102950697 0.14403262
NSC 729831 2-{4-[(1E)-3-pyridine-4-yltriaz-1-enyl]phenyl}-1H-benzimidaz ole 0.0430277102950697 0.20017951
NSC 730269 Null 0.0430277102950697 -0.15045336
NSC 748913 2,3-Dehydrosarcovagine D 0.0430277102950697 0.36973958
Total:136  Current:130    [First] [Prev] [Next] [Last]